India · Delayed Price · Currency is INR Alembic Pharmaceuticals Statistics
Total Valuation
BOM:533573 has a market cap or net worth of INR 153.87 billion. The enterprise value is 166.15 billion.
| Market Cap | 153.87B |
| Enterprise Value | 166.15B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Jul 29, 2026 |
Share Statistics
| Current Share Class | 196.56M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 5.53% |
| Owned by Institutions (%) | 16.62% |
| Float | 57.65M |
Valuation Ratios
The trailing PE ratio is 22.20 and the forward PE ratio is 19.44.
| PE Ratio | 22.20 |
| Forward PE | 19.44 |
| PS Ratio | 1.98 |
| PB Ratio | 2.71 |
| P/TBV Ratio | 2.86 |
| P/FCF Ratio | 44.20 |
| P/OCF Ratio | 19.66 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.40, with an EV/FCF ratio of 47.73.
| EV / Earnings | 23.96 |
| EV / Sales | 2.13 |
| EV / EBITDA | 14.40 |
| EV / EBIT | 20.15 |
| EV / FCF | 47.73 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.76 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.24 |
| Debt / FCF | 4.11 |
| Interest Coverage | 8.43 |
Financial Efficiency
Return on equity (ROE) is 12.36% and return on invested capital (ROIC) is 11.34%.
| Return on Equity (ROE) | 12.36% |
| Return on Assets (ROA) | 6.03% |
| Return on Invested Capital (ROIC) | 11.34% |
| Return on Capital Employed (ROCE) | 12.92% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 4.51M |
| Profits Per Employee | 402,146 |
| Employee Count | 17,244 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 0.87 |
Taxes
In the past 12 months, BOM:533573 has paid 361.40 million in taxes.
| Income Tax | 361.40M |
| Effective Tax Rate | 4.98% |
Stock Price Statistics
The stock price has decreased by -16.54% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -16.54% |
| 50-Day Moving Average | 816.42 |
| 200-Day Moving Average | 778.01 |
| Relative Strength Index (RSI) | 36.28 |
| Average Volume (20 Days) | 7,717 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:533573 had revenue of INR 77.84 billion and earned 6.93 billion in profits. Earnings per share was 35.28.
| Revenue | 77.84B |
| Gross Profit | 54.92B |
| Operating Income | 8.24B |
| Pretax Income | 7.26B |
| Net Income | 6.93B |
| EBITDA | 11.35B |
| EBIT | 8.24B |
| Earnings Per Share (EPS) | 35.28 |
Balance Sheet
The company has 1.96 billion in cash and 14.30 billion in debt, with a net cash position of -12.34 billion.
| Cash & Cash Equivalents | 1.96B |
| Total Debt | 14.30B |
| Net Cash | -12.34B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 56.69B |
| Book Value Per Share | 288.70 |
| Working Capital | 19.79B |
Cash Flow
In the last 12 months, operating cash flow was 7.83 billion and capital expenditures -4.35 billion, giving a free cash flow of 3.48 billion.
| Operating Cash Flow | 7.83B |
| Capital Expenditures | -4.35B |
| Depreciation & Amortization | 3.11B |
| Net Borrowing | 1.41B |
| Free Cash Flow | 3.48B |
| FCF Per Share | n/a |
Margins
Gross margin is 70.56%, with operating and profit margins of 10.58% and 8.91%.
| Gross Margin | 70.56% |
| Operating Margin | 10.58% |
| Pretax Margin | 9.32% |
| Profit Margin | 8.91% |
| EBITDA Margin | 14.58% |
| EBIT Margin | 10.58% |
| FCF Margin | 4.74% |
Dividends & Yields
This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 1.53%.
| Dividend Per Share | 12.00 |
| Dividend Yield | 1.53% |
| Dividend Growth (YoY) | 9.09% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 34.01% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | 1.50% |
| Earnings Yield | 4.50% |
| FCF Yield | 2.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:533573 is 961.80, which is 22.80% higher than the current price. The consensus rating is "Buy".
| Price Target | 961.80 |
| Price Target Difference | 22.80% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 11.83% |
| EPS Growth Forecast (3Y) | 14.75% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |